메뉴 건너뛰기




Volumn 3, Issue 3, 2009, Pages 211-220

Tiotropium bromide for chronic obstructive pulmonary disease

Author keywords

AECOPD; Bronchodilator; Chronic obstructive pulmonary disease; COPD; COPD exacerbation; Dyspnea; Inhaled anticholinergic; Lung function; Muscarinic receptor antagonist; Pharmacology; Safety; Tiotropium

Indexed keywords

ACETYLCHOLINE; ATROPINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; IPRATROPIUM BROMIDE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; PLACEBO; PREDNISONE; QUATERNARY AMMONIUM DERIVATIVE; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; TIOTROPIUM BROMIDE;

EID: 69949169999     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.09.19     Document Type: Review
Times cited : (12)

References (35)
  • 1
    • 40249111478 scopus 로고    scopus 로고
    • Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: A placebo-controlled trial
    • Tashkin DP, Littner M, Andrews CP, Tomlinson L, Rinehart M, Denis-Mize K. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial. Respir. Med. 102, 479-487 (2008).
    • (2008) Respir. Med , vol.102 , pp. 479-487
    • Tashkin, D.P.1    Littner, M.2    Andrews, C.P.3    Tomlinson, L.4    Rinehart, M.5    Denis-Mize, K.6
  • 2
    • 33745218112 scopus 로고    scopus 로고
    • Muscarinic receptor signaling in the pathophysiology of asthma and COPD
    • Gosens R, Zaagsma J, Meurs H, Halayko AJ. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir. Res. 7, 73 (2006).
    • (2006) Respir. Res , vol.7 , pp. 73
    • Gosens, R.1    Zaagsma, J.2    Meurs, H.3    Halayko, A.J.4
  • 5
    • 0035126934 scopus 로고    scopus 로고
    • Motor control of airway goblet cells and glands
    • Rogers DF. Motor control of airway goblet cells and glands. Respir. Physiol. 125, 129-144 (2001).
    • (2001) Respir. Physiol , vol.125 , pp. 129-144
    • Rogers, D.F.1
  • 6
    • 0035683136 scopus 로고    scopus 로고
    • The nonneuronal cholinergic system: An emerging drug target in the airways
    • Wessler IK, Kirkpatrick CJ. The nonneuronal cholinergic system: an emerging drug target in the airways. Pulm. Pharmacol. Ther. 14, 423-434 (2001).
    • (2001) Pulm. Pharmacol. Ther , vol.14 , pp. 423-434
    • Wessler, I.K.1    Kirkpatrick, C.J.2
  • 7
    • 0034099036 scopus 로고    scopus 로고
    • Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in sBox chronic obstructive pulmonary disease
    • Littner MR, Ilowite JS, Tashkin DP et al. Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in sBox chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 161, 1136-1142 (2000).
    • (2000) Am. J. Respir. Crit. Care Med , vol.161 , pp. 1136-1142
    • Littner, M.R.1    Ilowite, J.S.2    Tashkin, D.P.3
  • 8
    • 0036181956 scopus 로고    scopus 로고
    • A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
    • Casaburi R, Mahler DA, Jones PW et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur. Respir. J. 19, 217-224 (2002).
    • (2002) Eur. Respir. J , vol.19 , pp. 217-224
    • Casaburi, R.1    Mahler, D.A.2    Jones, P.W.3
  • 9
    • 33845938174 scopus 로고    scopus 로고
    • Pooled clinical trial analysis of tiotropium safety
    • Kesten S, Jara M, Wentworth C, Lanes S. Pooled clinical trial analysis of tiotropium safety. Chest 130, 1695-1703 (2006).
    • (2006) Chest , vol.130 , pp. 1695-1703
    • Kesten, S.1    Jara, M.2    Wentworth, C.3    Lanes, S.4
  • 10
    • 0034055236 scopus 로고    scopus 로고
    • A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group
    • van Noord JA, Bantje TA, Eland ME, Korducki L, Cornelissen PJ. A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group. Thorax55, 289-294 (2000).
    • (2000) Thorax , vol.55 , pp. 289-294
    • van Noord, J.A.1    Bantje, T.A.2    Eland, M.E.3    Korducki, L.4    Cornelissen, P.J.5
  • 11
    • 1042292620 scopus 로고    scopus 로고
    • One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease
    • Oostenbrink JB, Rutten-van Molken MP, Al MJ, Van Noord JA, Vincken W. One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease. Eur. Respir. J. 23, 241-249 (2004).
    • (2004) Eur. Respir. J , vol.23 , pp. 241-249
    • Oostenbrink, J.B.1    Rutten-van Molken MP, A.M.2    Van Noord, J.A.3    Vincken, W.4
  • 12
    • 0037879081 scopus 로고    scopus 로고
    • Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses
    • Tashkin D, Kesten S. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. Chest 123, 1441-1449 (2003).
    • (2003) Chest , vol.123 , pp. 1441-1449
    • Tashkin, D.1    Kesten, S.2
  • 13
    • 24644492301 scopus 로고    scopus 로고
    • Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: A randomized trial
    • Niewoehner DE, Rice K, Cote C et al. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial. Ann. Intern. Med. 143, 317-326 (2005).
    • (2005) Ann. Intern. Med , vol.143 , pp. 317-326
    • Niewoehner, D.E.1    Rice, K.2    Cote, C.3
  • 14
    • 33644859913 scopus 로고    scopus 로고
    • The effect of tiotropium on exacerbations and airflow in patients with COPD
    • Dusser D, Bravo ML, Iacono P. The effect of tiotropium on exacerbations and airflow in patients with COPD. Eur. Respir. J. 27, 547-555 (2006).
    • (2006) Eur. Respir. J , vol.27 , pp. 547-555
    • Dusser, D.1    Bravo, M.L.2    Iacono, P.3
  • 15
    • 0017402583 scopus 로고
    • The natural history of chronic airflow obstruction
    • Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br. Med. J. 1, 1645-1648 (1977).
    • (1977) Br. Med. J , vol.1 , pp. 1645-1648
    • Fletcher, C.1    Peto, R.2
  • 16
    • 0027962628 scopus 로고
    • Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study
    • Anthonisen NR, Connett JE, Kiley JP et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 272, 1497-1505 (1994).
    • (1994) JAMA , vol.272 , pp. 1497-1505
    • Anthonisen, N.R.1    Connett, J.E.2    Kiley, J.P.3
  • 18
    • 15844429415 scopus 로고    scopus 로고
    • Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD
    • Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 127, 809-817 (2005).
    • (2005) Chest , vol.127 , pp. 809-817
    • Casaburi, R.1    Kukafka, D.2    Cooper, C.B.3    Witek Jr, T.J.4    Kesten, S.5
  • 19
    • 11844265905 scopus 로고    scopus 로고
    • One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium
    • Anzueto A, Tashkin D, Menjoge S, Kesten S. One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. Pulm. Pharmacol. Ther. 18, 75-81 (2005).
    • (2005) Pulm. Pharmacol. Ther , vol.18 , pp. 75-81
    • Anzueto, A.1    Tashkin, D.2    Menjoge, S.3    Kesten, S.4
  • 20
    • 0038366897 scopus 로고    scopus 로고
    • Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD
    • Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax 58, 399-404 (2003).
    • (2003) Thorax , vol.58 , pp. 399-404
    • Brusasco, V.1    Hodder, R.2    Miravitlles, M.3    Korducki, L.4    Towse, L.5    Kesten, S.6
  • 21
    • 23144457098 scopus 로고    scopus 로고
    • Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD
    • van Noord JA, Aumann JL, Janssens E et al. Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. Eur. Respir. J. 26, 214-222 (2005).
    • (2005) Eur. Respir. J , vol.26 , pp. 214-222
    • van Noord, J.A.1    Aumann, J.L.2    Janssens, E.3
  • 22
    • 34247561439 scopus 로고    scopus 로고
    • Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: A randomized trial
    • Aaron SD, Vandemheen KL, Fergusson D et al.; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann. Intern. Med. 146, 545-555 (2007).
    • (2007) Ann. Intern. Med , vol.146 , pp. 545-555
    • Aaron, S.D.1    Vandemheen, K.L.2    Fergusson, D.3
  • 23
    • 37849011194 scopus 로고    scopus 로고
    • INSPIRE Investigators. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide
    • Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA; INSPIRE Investigators. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am. J. Respir. Crit. Care Med. 177, 19-26 (2008).
    • (2008) Am. J. Respir. Crit. Care Med , vol.177 , pp. 19-26
    • Wedzicha, J.A.1    Calverley, P.M.2    Seemungal, T.A.3    Hagan, G.4    Ansari, Z.5    Stockley, R.A.6
  • 24
    • 0029993821 scopus 로고    scopus 로고
    • Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma
    • O'Connor BJ, Towse LJ, Barnes PJ. Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma. Am. J. Respir. Crit. Care Med. 154, 876-880 (1996).
    • (1996) Am. J. Respir. Crit. Care Med , vol.154 , pp. 876-880
    • O'Connor, B.J.1    Towse, L.J.2    Barnes, P.J.3
  • 25
    • 37849014833 scopus 로고    scopus 로고
    • Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD
    • Powrie DJ, Wilkinson TM, Donaldson GC et al. Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Eur. Respir. J. 30, 472-478 (2007).
    • (2007) Eur. Respir. J , vol.30 , pp. 472-478
    • Powrie, D.J.1    Wilkinson, T.M.2    Donaldson, G.C.3
  • 26
    • 58149376396 scopus 로고    scopus 로고
    • Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts
    • Haag S, Matthiesen S, Juergens UR, Racke K. Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts. Eur. Respir. J. 32, 555-562 (2008).
    • (2008) Eur. Respir. J , vol.32 , pp. 555-562
    • Haag, S.1    Matthiesen, S.2    Juergens, U.R.3    Racke, K.4
  • 27
    • 38449113726 scopus 로고    scopus 로고
    • Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: A comparison
    • Bos IS, Gosens R, Zuidhof AB et al. Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. Eur. Respir. J. 30, 653-661 (2007).
    • (2007) Eur. Respir. J , vol.30 , pp. 653-661
    • Bos, I.S.1    Gosens, R.2    Zuidhof, A.B.3
  • 28
    • 18644380685 scopus 로고    scopus 로고
    • Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling
    • Gosens R, Bos IS, Zaagsma J, Meurs H. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Am. J. Respir. Crit. Care Med. 171, 1096-1102 (2005).
    • (2005) Am. J. Respir. Crit. Care Med , vol.171 , pp. 1096-1102
    • Gosens, R.1    Bos, I.S.2    Zaagsma, J.3    Meurs, H.4
  • 29
    • 0034047010 scopus 로고    scopus 로고
    • First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department
    • Rodrigo GJ, Rodrigo C. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department. Am. J. Respir. Crit. Care Med. 161, 1862-1868 (2000).
    • (2000) Am. J. Respir. Crit. Care Med , vol.161 , pp. 1862-1868
    • Rodrigo, G.J.1    Rodrigo, C.2
  • 30
    • 49649102385 scopus 로고    scopus 로고
    • Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype
    • Iwamoto H, Yokoyama A, Shiota N et al. Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype. Eur. Respir. J. 31, 1379-1380 (2008).
    • (2008) Eur. Respir. J , vol.31 , pp. 1379-1380
    • Iwamoto, H.1    Yokoyama, A.2    Shiota, N.3
  • 31
    • 3042549235 scopus 로고    scopus 로고
    • Tiotropium Sleep Study in COPD Investigators. Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD
    • McNicholas WT, Calverley PM, Lee A, Edwards JC; Tiotropium Sleep Study in COPD Investigators. Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD. Eur. Respir. J. 23, 825-831 (2004).
    • (2004) Eur. Respir. J , vol.23 , pp. 825-831
    • McNicholas, W.T.1    Calverley, P.M.2    Lee, A.3    Edwards, J.C.4
  • 33
    • 0037362716 scopus 로고    scopus 로고
    • Lanes S, Golisch W, Mikl J. Ipratropium and lung health study. Am. J. Respir. Crit. Care Med. 167, 801; author reply 801-802 (2003).
    • Lanes S, Golisch W, Mikl J. Ipratropium and lung health study. Am. J. Respir. Crit. Care Med. 167, 801; author reply 801-802 (2003).
  • 34
    • 52449106502 scopus 로고    scopus 로고
    • Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
    • Singh S, Loke YK, Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 300, 1439-1450 (2008).
    • (2008) JAMA , vol.300 , pp. 1439-1450
    • Singh, S.1    Loke, Y.K.2    Furberg, C.D.3
  • 35
    • 53749102775 scopus 로고    scopus 로고
    • UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease
    • Tashkin DP, Celli B, Senn S et al.; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N. Engl. J. Med. 359, 1543-1554 (2008).
    • (2008) N. Engl. J. Med , vol.359 , pp. 1543-1554
    • Tashkin, D.P.1    Celli, B.2    Senn, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.